Cellebrite
CLBT
141 hedge funds and large institutions have $836M invested in Cellebrite in 2024 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 56 increasing their positions, 35 reducing their positions, and 9 closing their positions.
5,588% more call options, than puts
Call options by funds: $6.26M | Put options by funds: $110K
289% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 9
60% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 35
22% more funds holding
Funds holding: 116 → 141 (+25)
12% more capital invested
Capital invested by funds: $749M → $836M (+$87.8M)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
6.87% less ownership
Funds ownership: 43.84% → 36.96% (-6.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
+$14.4M |
| 2 |
RCMC
RK Capital Management (Colorado)
Denver,
Colorado
|
+$13.2M |
| 3 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$11.7M |
| 4 |
KHLMVGHM
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet
Tel Aviv,
Israel
|
+$10.4M |
| 5 |
Walleye Capital
New York
|
+$8.54M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CI
Clal Insurance
Tel-Aviv,
Israel
|
-$10.3M |
| 2 |
PF
Phoenix Financial
Givatayim,
Israel
|
-$6.81M |
| 3 |
IP
Isomer Partners
New York
|
-$6.12M |
| 4 |
Millennium Management
New York
|
-$5.33M |
| 5 |
William Blair & Company
Chicago,
Illinois
|
-$4.22M |
CLBT Hedge Fund Activity: Q1 2024 in Review
141 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Cellebrite (CLBT) for Q1 2024, worth a combined $836M — up 12% from $749M a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new CLBT positions and 9 closed out — a net gain of 26 holders — while 56 added to existing stakes and 35 trimmed.
The largest buyer was Meitav Investment House, adding an estimated $14.4M. The largest seller was Clal Insurance, cutting an estimated $10.3M.
- 141 institutional investors held Cellebrite (CLBT) as of Q1 2024, up from 116 in Q4 2023.
- Funds reported $836M of Cellebrite stock for Q1 2024, up 12% quarter-over-quarter.
- 35 funds opened new Cellebrite positions in Q1 2024 and 9 closed out, a net change of +26 holders.
- The largest Cellebrite buyer in Q1 2024 was Meitav Investment House, an estimated $14.4M added.
- The largest Cellebrite seller in Q1 2024 was Clal Insurance, an estimated $10.3M sold.
Based on aggregated 13F filings for Q1 2024.